Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion type Assertion NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_head.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_provenance.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion evidence source_evidence_literature NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_provenance.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion SIO_000772 16633151 NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_provenance.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion wasDerivedFrom befree-20150227 NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_provenance.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion wasGeneratedBy ECO_0000203 NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_provenance.